Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast

International Journal of Cancer

Volumn 89, Issue 1, 2000, Pages 26-31

  Leong, Annabelle C K ^a   Hanby, Andrew M ^a   Potts, Henry W W ^b   Tan, David S P ^a   Skilton, Diana ^a   Ryder, Ken ^a   Harris, William H ^a   Liebmann, Rachel D ^a   Barnes, Diana M ^a   Gillett, Cheryl E ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN D1; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MELPHALAN; PROTEIN P27; PROTEIN P53; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CELL CYCLE; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN D1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MICROFILAMENT PROTEINS; MIDDLE AGED; MITOTIC INDEX; MUSCLE PROTEINS; PHENOTYPE; RECEPTORS, ESTROGEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034688189     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000120)89:1<26::AID-IJC5>3.0.CO;2-8     Document Type: Article

References (24)

1. ALLE, K.M., HENSHALL, S.M., FIELD, A.S. and SUTHERLAND, R.L., Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin. Cancer Res., 4, 847-854 (1998).
2. BARNES, D.M. and CAMPLEJOHN, R.S., p53, apoptosis and breast cancer. J. Mammary Gland Biol. Neoplasia, 1, 163-175 (1996).
3. BARNES, D.M., DUBLIN, E.A., FISHER, C.J., LEVISON, D.S. and MILLIS, R.R., Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Hum. Pathol., 24, 469-476 (1993).
4. BARNES, D.M., HARRIS, W.H., SMITH, P. and MILLIS, R.R., Immunohistochemical determination of oestrogen receptor: comparison of different methods of staining and correlation with clinical outcome of breast cancer. Brit. J. Cancer, 74, 1445-1451 (1996).
5. BARNES, D.M. and MILLIS, R.R., Oestrogen receptors: the history, the relevance, and the methods of evaluation. In: N. Kirkham and N. Lemoine (eds.), Progress in pathology. Vol. 2, pp 89-114, Churchill Livingstone, London (1995).
6. BLAMEY, R.W., Phenotypic drift does not happen but lots of interesting things do. Breast, 2, 190 (1993).
7. CATZAVELOS, C. and 12 OTHERS, Decreased levels of the cell cycle inhibitor p27 protein: prognostic implications in primary breast cancer. Nature (Med.), 3, 227-230 (1997).
8. DONNELLAN, R. and CHETTY, R., Cyclin D1 and human neoplasia. J. clin. Pathol. Mol. Pathol., 51, 1-7 (1998).
9. ELLIS, P.A., LONNING, P.E., BØRRESEN-DALE, A., AAS, T., GEISLER, S., AKSLEN, L.A., SALTER, I., SMITH, I.E. and DOWSETT, M., Absence of p21 expression is associated with abnormal p53 in human breast carcinomas. Brit. J. Cancer, 76, 480-485 (1997).
10. ELSTON, C.W. and ELLIS, I.O., Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer: Experience from a large study with long-lerm follow-up. Histopathology, 19, 403-410 (1991).
11. GILLETT, C., FANTL, V., FISHER, C., BARTEK, J., DICKSON, C., BARNES, D., PETERS, G., Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54, 1812-1817 (1994).
12. GILLETT, C.E., LEE, A.H.S., MILLIS, R.R., BARNES, D.M., Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. J. Pathol. 184, 396-400 (1998).
13. GILLETT, C., SMITH, P., GREGORY, W., RICHARDS, M., MILLIS, R. and PETERS, G., Cyclin D1 and prognosis in human breast cancer. Int. J. Cancer, 69, 92-99 (1996).
14. Kip1 expression and interaction with other cell cycle associated proteins in mammary carcinoma. J. Pathol., 187, 200-206 (1999).
15. LODA, M., CUKOR, B., TAM, S., LAVIN, P., FIORENTINO, M., DRAETTA, G., MILBURN, J.J. and PAGANO, M., Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature (Med.), 3, 231-234 (1997).
16. MCINTOSH, G.G., ANDERSON, J.J., MILTON, I., STEWARD, M., PARR, A.H., THOMAS, M.D., HENRY, J.A., ANGUS, B., LENNARD, T.W.J. and HORNE, C.H.W., Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene, 11, 885-891 (1995).
17. MILLIS, R.R., BARNES, D.M., LAMPEJO, O.T., EGAN, M.K. and SMITH, P., Tumour grade does not change between primary and recurrent mammary carcinoma. Europ. J. Cancer, 34, 548-553 (1998).
18. 1 complete the cell cycle. Proc. nat. Acad. Sci. (Wash.), 91, 8022-8026 (1994).
19. ROYLANCE, R., GORMAN, P., HARRIS, W., LIEBMANN, R., BARNES, D., HANBY, A. and SHEER, D., Comparative genomic hybridisation of breast tumours stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res., 59, 1433-1436 (1999).
20. SUTHERLAND, R.L., PRALL. O.W.J., ALLE, K.M., WILCKEN, N.R.C., HUI, R., BALL, J.R., SARCEVIC, B., HENSHALL, S.M., MUSGROVE, E.A. and WATTS, C.K.W., Cyclin-dependent kinases as downstream targets of oestrogen action: potential prognostic indicators and therapeutic targets. Endocrine-related Cancer, 4, 357-370 (1997).
21. TAN, P., CADY, B., WANNER, M., WORLAND, P., CUKOR, B., MAGI-GALLUZZI, C., LAVIN, P., DRAETTA, G., PAGANO, M. and LODA, M., The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res., 57, 1259-1263 (1997).
22. TAN, D.S.P., POTTS, H.W.W., LEONG, A.C.K., GILLETT, C.E., SKILTON, D., HARRIS, W.H., LIEBMANN, R.D. and HANBY, A.M., The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast. J. Pathol., 189, 20-27 (1999).
23. VAN DIEST, P.J., MICHALIDES, R.J., JANNINK, I., VAN DER VALK, P., PETERSE, H., DE JONG, J.S., MEIJER, C. and BAAK, J., Cyclin D1 expression in invasive breast cancer. Amer. J. Path., 150, 705-711 (1997).
24. WEINBERG, R.A., The retinoblastoma protein and cell cycle control. Cell, 81, 323-330 (1995).